China Universal Asset Management Co., Ltd.
13F Reported Value
ⓘ$1.7B
Holdings
513
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
China Universal Asset Management Co., Ltd. disclosed 513 positions worth $1.7B in its Form 13F-HR for Q2 2026, led by $NVDA (NVIDIA CORP) at 6.1% of the equity portfolio, followed by $AAPL and $MU. During the quarter the fund opened 45 new positions and exited 34 — including a new stake in $ONTO and a full exit from $AZN. The portfolio is most concentrated in Technology (54.5% of disclosed assets). All figures are sourced directly from China Universal Asset Management Co., Ltd.’s Form 13F-HR filing with the SEC under CIK 1906594.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 85.9#5
Quality
$101.3M506,424 sh - 76.4#84
Quality
$79.0M273,078 sh - 86.2#4
Quality
$69.1M59,879 sh - 78.2
Quality
$60.4M168,979 sh - 68.7
Quality
$59.6M249,927 sh - 79.8
Quality
$54.4M145,892 sh - 79.8
Quality
$47.9M82,470 sh - 84.5
Quality
$38.4M101,545 sh - 45.6
Quality
$37.3M267,454 sh - 79.6
Quality
$34.3M60,897 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| 85.9#5 | $101.3M | 506,424 | |
| 76.4#84 | $79.0M | 273,078 | |
| 86.2#4 | $69.1M | 59,879 | |
| 78.2 | $60.4M | 168,979 | |
| 68.7 | $59.6M | 249,927 | |
| 79.8 | $54.4M | 145,892 | |
| 79.8 | $47.9M | 82,470 | |
| 84.5 | $38.4M | 101,545 | |
| 45.6 | $37.3M | 267,454 | |
| 79.6 | $34.3M | 60,897 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of China Universal Asset Management Co., Ltd.'s 513 positions.
Showing top 10 of 513 holdings.
Sector Allocation
Technology
$912.2M
Healthcare
$313.5M
Financials
$136.0M
Consumer Discretionary
$130.6M
Industrials
$95.9M
Communication Services
$27.0M
Consumer Staples
$24.9M
Other
$9.1M
Full Holdings — China Universal Asset Management Co., Ltd. (Q2 2026)
All 513 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | NVIDIA CORP | $101.3M | 6.1% | +9% | 85.9 | |
| 2 | Apple Inc. | $79.0M | 4.7% | +12% | 76.4 | |
| 3 | MICRON TECHNOLOGY INC | $69.1M | 4.1% | +10% | 86.2 | |
| 4 | Alphabet Inc. | $60.4M | 3.6% | -0% | 78.2 | |
| 5 | AMAZON COM INC | $59.6M | 3.6% | +23% | 68.7 | |
| 6 | MICROSOFT CORP | $54.4M | 3.3% | +9% | 79.8 | |
| 7 | ADVANCED MICRO DEVICES INC | $47.9M | 2.9% | +6% | 79.8 | |
| 8 | Broadcom Inc. | $38.4M | 2.3% | +5% | 84.5 | |
| 9 | INTEL CORP | $37.3M | 2.2% | +19% | 45.6 | |
| 10 | Meta Platforms, Inc. | $34.3M | 2.0% | +14% | 79.6 | |
| 11 | APPLIED MATERIALS INC /DE | $29.7M | 1.8% | +10% | 72.3 | |
| 12 | Alphabet Inc. | $29.1M | 1.7% | +17% | 78.2 | |
| 13 | LAM RESEARCH CORP | $28.5M | 1.7% | +8% | 79.4 | |
| 14 | Tesla, Inc. | $28.3M | 1.7% | +11% | 53.9 | |
| 15 | AMGEN INC | $26.1M | 1.6% | +16% | 79.2 | |
| 16 | VERTEX PHARMACEUTICALS INC / MA | $24.0M | 1.4% | +10% | 75.4 | |
| 17 | Sandisk Corp | $23.0M | 1.4% | +102% | 87.7 | |
| 18 | ISHARES GOLD TRUST | $22.5M | 1.4% | -24% | — | |
| 19 | SPDR GOLD TRUST | $21.9M | 1.3% | -23% | — | |
| 20 | World Gold Trust | $21.7M | 1.3% | -22% | — | |
| 21 | Walmart Inc. | $21.5M | 1.3% | +27% | 60.2 | |
| 22 | CISCO SYSTEMS, INC. | $20.8M | 1.3% | +17% | 70.3 | |
| 23 | KLA CORP | $20.6M | 1.2% | +915% | 78.6 | |
| 24 | GILEAD SCIENCES, INC. | $20.4M | 1.2% | +3% | 57.4 | |
| 25 | COSTCO WHOLESALE CORP /NEW | $16.7M | 1.0% | +12% | 66.2 | |
| 26 | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $16.0M | 1.0% | +16% | — | |
| 27 | WESTERN DIGITAL CORP | $15.6M | 0.9% | +6% | 80.7 | |
| 28 | Marvell Technology, Inc. | $15.4M | 0.9% | +111% | 76.5 | |
| 29 | NETFLIX INC | $15.2M | 0.9% | +6% | 78.8 | |
| 30 | ANALOG DEVICES INC | $14.1M | 0.8% | +8% | 79.2 | |
| 31 | iShares Gold Trust Micro | $14.1M | 0.8% | +6% | — | |
| 32 | Palo Alto Networks Inc | $14.0M | 0.8% | -2% | 65.5 | |
| 33 | REGENERON PHARMACEUTICALS, INC. | $12.2M | 0.7% | -9% | 71 | |
| 34 | GraniteShares Gold Trust | $12.0M | 0.7% | +0% | — | |
| 35 | Palantir Technologies Inc. | $11.5M | 0.7% | +4% | 84.6 | |
| 36 | ELI LILLY & Co | $10.9M | 0.7% | +111% | 87.5 | |
| 37 | abrdn Gold ETF Trust | $10.6M | 0.6% | +0% | — | |
| 38 | Lumentum Holdings Inc. | $10.1M | 0.6% | +31% | 44.3 | |
| 39 | TEXAS INSTRUMENTS INC | $9.7M | 0.6% | +9% | 73.4 | |
| 40 | Goldman Sachs Physical Gold ETF | $9.6M | 0.6% | +0% | — | |
| 41 | ASML HOLDING NV | $9.5M | 0.6% | +23% | — | |
| 42 | QUALCOMM INC/DE | $8.4M | 0.5% | +43% | 70.5 | |
| 43 | LINDE PLC | $8.2M | 0.5% | +10% | — | |
| 44 | AppLovin Corp | $8.1M | 0.5% | +4% | 84.4 | |
| 45 | CrowdStrike Holdings, Inc. | $7.8M | 0.5% | +6% | 67.7 | |
| 46 | NOVARTIS AG | $7.7M | 0.5% | -8% | — | |
| 47 | ALNYLAM PHARMACEUTICALS, INC. | $7.6M | 0.5% | -7% | 71.4 | |
| 48 | — | PROSHARES ULTRA GOLD - ETP | $7.3M | 0.4% | -19% | — |
| 49 | JOHNSON & JOHNSON | $7.2M | 0.4% | -1% | 69 | |
| 50 | Royalty Pharma plc | $6.8M | 0.4% | -8% | — | |
| 51 | VISA INC. | $6.5M | 0.4% | -10% | 82.9 | |
| 52 | Seagate Technology Holdings plc | $6.5M | 0.4% | +10% | — | |
| 53 | TERADYNE, INC | $6.4M | 0.4% | +48% | 77.3 | |
| 54 | Revolution Medicines, Inc. | $6.3M | 0.4% | -4% | — | |
| 55 | PEPSICO INC | $6.3M | 0.4% | +10% | 63.4 | |
| 56 | IONIS PHARMACEUTICALS INC | $6.0M | 0.4% | -1% | 23.4 | |
| 57 | T-Mobile US, Inc. | $5.5M | 0.3% | +5% | 69.1 | |
| 58 | INTUITIVE SURGICAL INC | $5.2M | 0.3% | -0% | 79.9 | |
| 59 | BIOGEN INC. | $5.1M | 0.3% | -10% | 64.7 | |
| 60 | ARM HOLDINGS PLC /UK | $4.9M | 0.3% | +248% | — | |
| 61 | SYNOPSYS INC | $4.8M | 0.3% | +4% | 67.9 | |
| 62 | CADENCE DESIGN SYSTEMS INC | $4.7M | 0.3% | +12% | 72.6 | |
| 63 | Datadog, Inc. | $4.6M | 0.3% | +4% | 71.4 | |
| 64 | HOME DEPOT, INC. | $4.6M | 0.3% | -1% | 60.3 | |
| 65 | COHERENT CORP. | $4.5M | 0.3% | -8% | 58.5 | |
| 66 | SHOPIFY INC. | $4.5M | 0.3% | -29% | 64.9 | |
| 67 | Moderna, Inc. | $4.4M | 0.3% | -10% | 21.2 | |
| 68 | ASE Technology Holding Co., Ltd. | $4.4M | 0.3% | +51% | — | |
| 69 | Mastercard Inc | $4.4M | 0.3% | -1% | 85.1 | |
| 70 | ARGENX SE | $4.3M | 0.3% | -8% | — | |
| 71 | Roivant Sciences Ltd. | $4.2M | 0.3% | -6% | — | |
| 72 | Booking Holdings Inc. | $4.2M | 0.3% | +1475% | 58.5 | |
| 73 | ONTO INNOVATION INC. | $3.9M | 0.2% | NEW | 61.9 | |
| 74 | Merck & Co., Inc. | $3.8M | 0.2% | +320% | 59.9 | |
| 75 | Astera Labs, Inc. | $3.8M | 0.2% | +191% | 75.1 | |
| 76 | AMPHENOL CORP /DE/ | $3.7M | 0.2% | +0% | 79.3 | |
| 77 | INSMED Inc | $3.7M | 0.2% | -27% | 39.4 | |
| 78 | UNITED THERAPEUTICS Corp | $3.7M | 0.2% | -13% | 71.3 | |
| 79 | INCYTE CORP | $3.6M | 0.2% | -10% | 77.4 | |
| 80 | STARBUCKS CORP | $3.5M | 0.2% | +7% | 58.2 | |
| 81 | UNITEDHEALTH GROUP INC | $3.5M | 0.2% | +224% | 62.7 | |
| 82 | JPMORGAN CHASE & CO | $3.4M | 0.2% | +35% | 70.7 | |
| 83 | DoorDash, Inc. | $3.4M | 0.2% | -3% | 71 | |
| 84 | Fortinet, Inc. | $3.4M | 0.2% | +6% | 80.1 | |
| 85 | MERCADOLIBRE INC | $3.3M | 0.2% | +5% | 80.2 | |
| 86 | Guardant Health, Inc. | $3.2M | 0.2% | -9% | 39 | |
| 87 | COCA COLA CO | $3.1M | 0.2% | -23% | 69.5 | |
| 88 | MICROCHIP TECHNOLOGY INC | $3.0M | 0.2% | +22% | 52.9 | |
| 89 | Viatris Inc | $2.9M | 0.2% | -9% | 45.4 | |
| 90 | MARRIOTT INTERNATIONAL INC /MD/ | $2.9M | 0.2% | +7% | 61.7 | |
| 91 | Vertiv Holdings Co | $2.9M | 0.2% | -6% | 81 | |
| 92 | MCDONALDS CORP | $2.9M | 0.2% | +18% | 69 | |
| 93 | Monster Beverage Corp | $2.8M | 0.2% | +7% | 71.3 | |
| 94 | TTM TECHNOLOGIES INC | $2.8M | 0.2% | -17% | 62.6 | |
| 95 | PDD Holdings Inc. | $2.8M | 0.2% | +13% | — | |
| 96 | MONOLITHIC POWER SYSTEMS, INC. | $2.7M | 0.2% | +34% | 73.3 | |
| 97 | Airbnb, Inc. | $2.7M | 0.2% | +60% | 71 | |
| 98 | BERKSHIRE HATHAWAY INC | $2.7M | 0.2% | +39% | 73.8 | |
| 99 | AUTOMATIC DATA PROCESSING INC | $2.7M | 0.2% | +6% | 69.8 | |
| 100 | Constellation Energy Corp | $2.7M | 0.2% | +7% | 59.4 | |
| 101 | NEUROCRINE BIOSCIENCES INC | $2.7M | 0.2% | -10% | 76.5 | |
| 102 | CSX CORP | $2.7M | 0.2% | +7% | 65.2 | |
| 103 | COMCAST CORP | $2.6M | 0.2% | +6% | 59.5 | |
| 104 | Ascendis Pharma A/S | $2.6M | 0.2% | -10% | 44.8 | |
| 105 | NOKIA CORP | $2.6M | 0.2% | NEW | — | |
| 106 | CELESTICA INC | $2.6M | 0.1% | +10% | 69.8 | |
| 107 | ADOBE INC. | $2.5M | 0.1% | +6% | 77.6 | |
| 108 | TOWER SEMICONDUCTOR LTD | $2.5M | 0.1% | +14% | — | |
| 109 | Medpace Holdings, Inc. | $2.4M | 0.1% | -10% | 76.2 | |
| 110 | Jazz Pharmaceuticals plc | $2.4M | 0.1% | -9% | — | |
| 111 | Ferrari N.V. | $2.3M | 0.1% | -19% | — | |
| 112 | BridgeBio Pharma, Inc. | $2.3M | 0.1% | -9% | 36.9 | |
| 113 | O REILLY AUTOMOTIVE INC | $2.3M | 0.1% | +6% | 67.4 | |
| 114 | British American Tobacco p.l.c. | $2.3M | 0.1% | -55% | — | |
| 115 | Mondelez International, Inc. | $2.3M | 0.1% | +7% | 56.4 | |
| 116 | GE Vernova Inc. | $2.3M | 0.1% | +148% | 81.1 | |
| 117 | Uber Technologies, Inc | $2.3M | 0.1% | +0% | 73.5 | |
| 118 | AMERICAN ELECTRIC POWER CO INC | $2.2M | 0.1% | +8% | 66.8 | |
| 119 | Keysight Technologies, Inc. | $2.2M | 0.1% | +42% | 71.4 | |
| 120 | EXXON MOBIL CORP | $2.2M | 0.1% | +35% | 57.9 | |
| 121 | EXELIXIS, INC. | $2.2M | 0.1% | -13% | 76.2 | |
| 122 | INTUIT INC. | $2.1M | 0.1% | -34% | 79.3 | |
| 123 | NXP Semiconductors N.V. | $2.1M | 0.1% | +7% | — | |
| 124 | PROCTER & GAMBLE Co | $2.1M | 0.1% | +97% | 64.6 | |
| 125 | HONEYWELL INTERNATIONAL INC | $2.1M | 0.1% | -47% | 65 | |
| 126 | NetEase, Inc. | $2.1M | 0.1% | +0% | — | |
| 127 | Honeywell Aerospace Inc. | $2.1M | 0.1% | NEW | — | |
| 128 | ROSS STORES, INC. | $2.1M | 0.1% | +7% | 70.4 | |
| 129 | CINTAS CORP | $2.0M | 0.1% | +7% | 68.7 | |
| 130 | Autodesk, Inc. | $2.0M | 0.1% | -13% | 78.6 | |
| 131 | Warner Bros. Discovery, Inc. | $2.0M | 0.1% | +8% | 41.4 | |
| 132 | THERMO FISHER SCIENTIFIC INC. | $2.0M | 0.1% | +25% | 65.1 | |
| 133 | Axsome Therapeutics, Inc. | $2.0M | 0.1% | -10% | 40.8 | |
| 134 | MADRIGAL PHARMACEUTICALS, INC. | $2.0M | 0.1% | -14% | 40.7 | |
| 135 | Summit Therapeutics Inc. | $1.9M | 0.1% | -3% | — | |
| 136 | CATERPILLAR INC | $1.9M | 0.1% | +36% | 66.5 | |
| 137 | PACCAR INC | $1.9M | 0.1% | +7% | 56.5 | |
| 138 | STMicroelectronics N.V. | $1.9M | 0.1% | +39% | — | |
| 139 | CVS HEALTH Corp | $1.9M | 0.1% | +13% | 59.4 | |
| 140 | CYTOKINETICS INC | $1.8M | 0.1% | -1% | 28.1 | |
| 141 | Nebius Group N.V. | $1.8M | 0.1% | NEW | — | |
| 142 | ARROWHEAD PHARMACEUTICALS, INC. | $1.8M | 0.1% | -10% | 38.7 | |
| 143 | Rocket Lab Corp | $1.8M | 0.1% | NEW | 39.9 | |
| 144 | BIOMARIN PHARMACEUTICAL INC | $1.8M | 0.1% | -10% | 58.2 | |
| 145 | Krystal Biotech, Inc. | $1.7M | 0.1% | -10% | 79.2 | |
| 146 | AbbVie Inc. | $1.7M | 0.1% | +37% | 72.6 | |
| 147 | BioNTech SE | $1.7M | 0.1% | -9% | — | |
| 148 | FASTENAL CO | $1.7M | 0.1% | +7% | 66.9 | |
| 149 | Baker Hughes Co | $1.7M | 0.1% | +7% | 60.7 | |
| 150 | NewAmsterdam Pharma Co N.V. | $1.6M | 0.1% | +11% | — | |
| 151 | Tempus AI, Inc. | $1.6M | 0.1% | -10% | 41.2 | |
| 152 | Sanofi | $1.6M | 0.1% | -15% | — | |
| 153 | BRISTOL MYERS SQUIBB CO | $1.6M | 0.1% | +25% | 70.4 | |
| 154 | ELECTRONIC ARTS INC. | $1.5M | 0.1% | +7% | 62.9 | |
| 155 | MAXLINEAR, INC | $1.5M | 0.1% | NEW | 33.1 | |
| 156 | GENERAL ELECTRIC CO | $1.5M | 0.1% | +36% | 73.8 | |
| 157 | ON SEMICONDUCTOR CORP | $1.5M | 0.1% | +148% | 55 | |
| 158 | XCEL ENERGY INC | $1.5M | 0.1% | +7% | 56.4 | |
| 159 | BANK OF AMERICA CORP /DE/ | $1.5M | 0.1% | +36% | 67.6 | |
| 160 | Kymera Therapeutics, Inc. | $1.5M | 0.1% | -10% | 28.4 | |
| 161 | BeOne Medicines Ltd. | $1.5M | 0.1% | -7% | — | |
| 162 | Diamondback Energy, Inc. | $1.5M | 0.1% | +7% | 76.1 | |
| 163 | FORMFACTOR INC | $1.5M | 0.1% | NEW | 60 | |
| 164 | Ferrovial N.V. | $1.5M | 0.1% | +7% | — | |
| 165 | Praxis Precision Medicines, Inc. | $1.5M | 0.1% | -10% | — | |
| 166 | HALOZYME THERAPEUTICS, INC. | $1.5M | 0.1% | -10% | 77.2 | |
| 167 | ImmunityBio, Inc. | $1.5M | 0.1% | -9% | 31.5 | |
| 168 | Nuvalent, Inc. | $1.4M | 0.1% | -10% | — | |
| 169 | IDEXX LABORATORIES INC /DE | $1.4M | 0.1% | +22% | 73.8 | |
| 170 | STRYKER CORP | $1.4M | 0.1% | -0% | 72.1 | |
| 171 | EXELON CORP | $1.4M | 0.1% | +7% | 59.6 | |
| 172 | Protagonist Therapeutics, Inc | $1.4M | 0.1% | -23% | 59.4 | |
| 173 | TAKE TWO INTERACTIVE SOFTWARE INC | $1.4M | 0.1% | +7% | 55.6 | |
| 174 | Alkermes plc. | $1.4M | 0.1% | -10% | — | |
| 175 | AXON ENTERPRISE, INC. | $1.4M | 0.1% | +7% | 56.6 | |
| 176 | OLD DOMINION FREIGHT LINE, INC. | $1.4M | 0.1% | +7% | 61.3 | |
| 177 | Keurig Dr Pepper Inc. | $1.3M | 0.1% | +7% | 64.6 | |
| 178 | COCA-COLA EUROPACIFIC PARTNERS plc | $1.3M | 0.1% | +4% | — | |
| 179 | CoreWeave, Inc. | $1.3M | 0.1% | NEW | 52.2 | |
| 180 | Vaxcyte, Inc. | $1.3M | 0.1% | -10% | — | |
| 181 | Apogee Therapeutics, Inc. | $1.3M | 0.1% | +1% | — | |
| 182 | Immunovant, Inc. | $1.3M | 0.1% | -10% | — | |
| 183 | Design Therapeutics, Inc. | $1.3M | 0.1% | +156% | — | |
| 184 | Abivax S.A. | $1.2M | 0.1% | -29% | — | |
| 185 | Unity Software Inc. | $1.2M | 0.1% | +0% | 38.9 | |
| 186 | Spyre Therapeutics, Inc. | $1.2M | 0.1% | -1% | — | |
| 187 | RHYTHM PHARMACEUTICALS, INC. | $1.2M | 0.1% | -10% | 33.9 | |
| 188 | MCKESSON CORP | $1.2M | 0.1% | +0% | 63.4 | |
| 189 | CHEVRON CORP | $1.2M | 0.1% | +32% | 62.8 | |
| 190 | GOLDMAN SACHS GROUP INC | $1.2M | 0.1% | +35% | 73.5 | |
| 191 | PayPal Holdings, Inc. | $1.1M | 0.1% | +3% | 64.1 | |
| 192 | Mirum Pharmaceuticals, Inc. | $1.1M | 0.1% | -9% | 35 | |
| 193 | Philip Morris International Inc. | $1.1M | 0.1% | +37% | 75.9 | |
| 194 | Cloudflare, Inc. | $1.1M | 0.1% | +0% | 56.4 | |
| 195 | Erasca, Inc. | $1.1M | 0.1% | +8% | — | |
| 196 | PTC THERAPEUTICS, INC. | $1.1M | 0.1% | -10% | 35.4 | |
| 197 | PAYCHEX INC | $1.1M | 0.1% | +7% | 74.6 | |
| 198 | Cogent Biosciences, Inc. | $1.1M | 0.1% | -6% | — | |
| 199 | Scholar Rock Holding Corp | $1.0M | 0.1% | +5% | — | |
| 200 | INTERNATIONAL BUSINESS MACHINES CORP | $1.0M | 0.1% | +38% | 70 | |
| 201 | ROPER TECHNOLOGIES INC | $1.0M | 0.1% | +5% | 71.9 | |
| 202 | Twist Bioscience Corp | $1.0M | 0.1% | -9% | 33.9 | |
| 203 | LIGAND PHARMACEUTICALS INC | $1.0M | 0.1% | -10% | 76 | |
| 204 | Definium Therapeutics, Inc. | $1.0M | 0.1% | +6% | — | |
| 205 | RTX Corp | $997,980 | 0.1% | +38% | 73.2 | |
| 206 | CG Oncology, Inc. | $997,329 | 0.1% | -6% | 27 | |
| 207 | WELLS FARGO & COMPANY/MN | $989,697 | 0.1% | +34% | 61.8 | |
| 208 | ORACLE CORP | $988,333 | 0.1% | +37% | 66.2 | |
| 209 | Natera, Inc. | $977,220 | 0.1% | +55% | 53.5 | |
| 210 | MORGAN STANLEY | $968,064 | 0.1% | +37% | 75.8 | |
| 211 | DEXCOM INC | $950,915 | 0.1% | +10% | 76 | |
| 212 | THOMSON REUTERS CORP /CAN/ | $937,082 | 0.1% | -8% | 58.7 | |
| 213 | Xenon Pharmaceuticals Inc. | $928,578 | 0.1% | +4% | 24 | |
| 214 | Oruka Therapeutics, Inc. | $913,537 | 0.1% | +12% | — | |
| 215 | Tango Therapeutics, Inc. | $907,196 | 0.1% | +21% | 17.6 | |
| 216 | Amneal Pharmaceuticals, Inc. | $878,881 | 0.1% | -9% | 58.5 | |
| 217 | GE HealthCare Technologies Inc. | $876,745 | 0.1% | +7% | 55.7 | |
| 218 | Strategy Inc | $865,910 | 0.1% | +13% | 17.9 | |
| 219 | Kraft Heinz Co | $843,328 | 0.1% | +7% | 47 | |
| 220 | Travere Therapeutics, Inc. | $840,788 | 0.1% | -25% | 56.6 | |
| 221 | CRISPR Therapeutics AG | $837,189 | 0.1% | -10% | 9.7 | |
| 222 | Kanzhun Ltd | $836,550 | 0.1% | +8% | — | |
| 223 | Credo Technology Group Holding Ltd | $815,850 | 0.1% | +0% | 55.1 | |
| 224 | Hewlett Packard Enterprise Co | $814,032 | 0.1% | NEW | 70.5 | |
| 225 | Caris Life Sciences, Inc. | $801,704 | 0.1% | -10% | 69 | |
| 226 | Indivior Pharmaceuticals, Inc. | $796,146 | 0.1% | -13% | 58.5 | |
| 227 | COPART INC | $785,824 | 0.1% | +2% | 69.1 | |
| 228 | Dell Technologies Inc. | $776,628 | 0.1% | NEW | 71.2 | |
| 229 | Denali Therapeutics Inc. | $766,945 | 0.1% | -27% | — | |
| 230 | Rubrik, Inc. | $762,660 | 0.1% | -5% | 56.6 | |
| 231 | Edgewise Therapeutics, Inc. | $746,495 | 0.0% | -28% | — | |
| 232 | VERACYTE, INC. | $745,812 | 0.0% | -10% | 68.6 | |
| 233 | Workday, Inc. | $740,886 | 0.0% | +1% | 75.5 | |
| 234 | Sarepta Therapeutics, Inc. | $720,633 | 0.0% | +70% | 47.3 | |
| 235 | 10x Genomics, Inc. | $713,162 | 0.0% | -11% | 40.5 | |
| 236 | — | SS CONSUMER DISC SELECT SECT - ETP | $707,198 | 0.0% | +0% | — |
| 237 | VERIZON COMMUNICATIONS INC | $691,709 | 0.0% | +36% | 65.8 | |
| 238 | ACADIA PHARMACEUTICALS INC | $689,476 | 0.0% | -10% | 67.8 | |
| 239 | Crinetics Pharmaceuticals, Inc. | $687,817 | 0.0% | -1% | 25.5 | |
| 240 | CIENA CORP | $686,784 | 0.0% | -59% | 72.9 | |
| 241 | TAL Education Group | $669,900 | 0.0% | -45% | — | |
| 242 | Structure Therapeutics Inc. | $665,991 | 0.0% | -10% | — | |
| 243 | Relay Therapeutics, Inc. | $638,722 | 0.0% | +8% | 19.5 | |
| 244 | GRAIL, Inc. | $636,959 | 0.0% | +14% | 31.6 | |
| 245 | TJX COMPANIES INC /DE/ | $636,300 | 0.0% | -68% | 68.7 | |
| 246 | SITIME Corp | $633,726 | 0.0% | NEW | 66.1 | |
| 247 | TWILIO INC | $618,990 | 0.0% | -68% | 70.4 | |
| 248 | Disc Medicine, Inc. | $602,600 | 0.0% | -2% | — | |
| 249 | Cigna Group | $595,469 | 0.0% | -28% | 66.2 | |
| 250 | Dyne Therapeutics, Inc. | $584,345 | 0.0% | -10% | — | |
| 251 | VICOR CORP | $569,670 | 0.0% | +0% | 58.1 | |
| 252 | IDEAYA Biosciences, Inc. | $568,107 | 0.0% | -2% | 36.1 | |
| 253 | Atour Lifestyle Holdings Ltd | $564,450 | 0.0% | -50% | — | |
| 254 | Beam Therapeutics Inc. | $561,921 | 0.0% | -9% | 34.2 | |
| 255 | ALUMIS INC. | $552,782 | 0.0% | -12% | 7.1 | |
| 256 | EyePoint, Inc. | $548,305 | 0.0% | -3% | 3.5 | |
| 257 | Adaptive Biotechnologies Corp | $546,353 | 0.0% | -12% | 41.4 | |
| 258 | Okta, Inc. | $545,800 | 0.0% | NEW | 64.7 | |
| 259 | BOSTON SCIENTIFIC CORP | $533,500 | 0.0% | -50% | 77.5 | |
| 260 | Ultragenyx Pharmaceutical Inc. | $523,388 | 0.0% | -9% | 34.2 | |
| 261 | VNET Group, Inc. | $522,600 | 0.0% | +0% | — | |
| 262 | Arcutis Biotherapeutics, Inc. | $521,962 | 0.0% | -10% | 62.9 | |
| 263 | Pharvaris N.V. | $508,983 | 0.0% | +29% | — | |
| 264 | MBX Biosciences, Inc. | $506,460 | 0.0% | +15% | — | |
| 265 | HUMANA INC | $497,521 | 0.0% | NEW | 58.9 | |
| 266 | — | PGIM ULTRA SHORT BOND ETF - ETP | $496,984 | 0.0% | NEW | — |
| 267 | Enliven Therapeutics, Inc. | $491,920 | 0.0% | -8% | — | |
| 268 | Vera Therapeutics, Inc. | $490,204 | 0.0% | -10% | — | |
| 269 | AGILENT TECHNOLOGIES, INC. | $479,014 | 0.0% | +0% | 67.1 | |
| 270 | Zenas BioPharma, Inc. | $478,362 | 0.0% | +39% | 7.4 | |
| 271 | Kiniksa Pharmaceuticals International, plc | $471,248 | 0.0% | -10% | — | |
| 272 | uniQure N.V. | $462,304 | 0.0% | -9% | — | |
| 273 | Rapport Therapeutics, Inc. | $450,536 | 0.0% | -10% | — | |
| 274 | Taysha Gene Therapies, Inc. | $447,649 | 0.0% | +35% | 4.9 | |
| 275 | Zeta Global Holdings Corp. | $432,960 | 0.0% | +0% | 63.4 | |
| 276 | Trevi Therapeutics, Inc. | $432,605 | 0.0% | -29% | — | |
| 277 | Tarsus Pharmaceuticals, Inc. | $430,950 | 0.0% | -9% | 55 | |
| 278 | SUPERNUS PHARMACEUTICALS, INC. | $429,613 | 0.0% | -9% | 41.9 | |
| 279 | DECKERS OUTDOOR CORP | $416,323 | 0.0% | +85% | 70 | |
| 280 | Maze Therapeutics, Inc. | $412,031 | 0.0% | +15% | 10.3 | |
| 281 | BIOCRYST PHARMACEUTICALS INC | $404,500 | 0.0% | -9% | 53.2 | |
| 282 | Absci Corp | $403,471 | 0.0% | -18% | 7 | |
| 283 | Nurix Therapeutics, Inc. | $399,247 | 0.0% | -10% | 6.4 | |
| 284 | Trip.com Group Ltd | $398,400 | 0.0% | -53% | — | |
| 285 | Kodiak Sciences Inc. | $388,003 | 0.0% | -8% | — | |
| 286 | Legend Biotech Corp | $387,945 | 0.0% | -10% | 47.8 | |
| 287 | AbCellera Biologics Inc. | $381,518 | 0.0% | -10% | 29.3 | |
| 288 | Atai Beckley N.V. | $380,352 | 0.0% | -4% | — | |
| 289 | NIO Inc. | $379,500 | 0.0% | +0% | — | |
| 290 | Intellia Therapeutics, Inc. | $376,250 | 0.0% | -34% | 19.9 | |
| 291 | TENET HEALTHCARE CORP | $374,160 | 0.0% | -69% | 66.2 | |
| 292 | Monte Rosa Therapeutics, Inc. | $364,089 | 0.0% | +11% | 30.3 | |
| 293 | Vericel Corp | $361,615 | 0.0% | -10% | 62.8 | |
| 294 | Septerna, Inc. | $360,821 | 0.0% | -10% | 59.2 | |
| 295 | GH Research PLC | $360,703 | 0.0% | -1% | — | |
| 296 | Annexon, Inc. | $354,454 | 0.0% | +8% | — | |
| 297 | Mineralys Therapeutics, Inc. | $354,247 | 0.0% | -7% | — | |
| 298 | AGIOS PHARMACEUTICALS, INC. | $351,246 | 0.0% | -9% | 26.9 | |
| 299 | Aurinia Pharmaceuticals Inc. | $347,325 | 0.0% | -13% | 75.2 | |
| 300 | OCULAR THERAPEUTIX, INC | $342,207 | 0.0% | -10% | 8.4 | |
| 301 | REPLIGEN CORP | $341,100 | 0.0% | -22% | 58.4 | |
| 302 | QUEST DIAGNOSTICS INC | $339,120 | 0.0% | +0% | 69 | |
| 303 | Hilton Worldwide Holdings Inc. | $337,400 | 0.0% | +0% | 63.3 | |
| 304 | Harmony Biosciences Holdings, Inc. | $335,482 | 0.0% | -10% | 71.4 | |
| 305 | Alibaba Group Holding Ltd | $334,199 | 0.0% | -82% | — | |
| 306 | GENMAB A/S | $331,755 | 0.0% | +6% | 77.9 | |
| 307 | Stoke Therapeutics, Inc. | $330,865 | 0.0% | -33% | 24.9 | |
| 308 | PRECIGEN, INC. | $323,412 | 0.0% | -10% | 29.6 | |
| 309 | Corvus Pharmaceuticals, Inc. | $319,462 | 0.0% | -21% | — | |
| 310 | Amylyx Pharmaceuticals, Inc. | $317,802 | 0.0% | -9% | 8.7 | |
| 311 | Sionna Therapeutics, Inc. | $316,112 | 0.0% | -9% | — | |
| 312 | Salesforce, Inc. | $314,112 | 0.0% | NEW | 77 | |
| 313 | ANAPTYSBIO, INC | $312,593 | 0.0% | -25% | 48.4 | |
| 314 | Atlassian Corp | $311,160 | 0.0% | -16% | 65.8 | |
| 315 | Bicara Therapeutics Inc. | $310,468 | 0.0% | -7% | — | |
| 316 | Elevance Health, Inc. | $309,384 | 0.0% | -36% | 59 | |
| 317 | ADMA BIOLOGICS, INC. | $308,744 | 0.0% | -13% | 69.7 | |
| 318 | Syndax Pharmaceuticals Inc | $308,270 | 0.0% | -10% | 33.8 | |
| 319 | RECURSION PHARMACEUTICALS, INC. | $306,456 | 0.0% | -10% | 23.3 | |
| 320 | INSULET CORP | $304,500 | 0.0% | +25% | 71.3 | |
| 321 | Zymeworks Inc. | $303,799 | 0.0% | -12% | 8.7 | |
| 322 | Tyra Biosciences, Inc. | $302,312 | 0.0% | -0% | — | |
| 323 | COMPASS Pathways plc | $299,739 | 0.0% | +27% | — | |
| 324 | ANI PHARMACEUTICALS INC | $299,498 | 0.0% | -9% | 72.5 | |
| 325 | IOVANCE BIOTHERAPEUTICS, INC. | $295,614 | 0.0% | -3% | 36.8 | |
| 326 | UroGen Pharma Ltd. | $285,347 | 0.0% | -7% | — | |
| 327 | NovoCure Ltd | $279,260 | 0.0% | -9% | — | |
| 328 | — | VANGUARD ULTRA SHORT BOND ET - ETP | $278,768 | 0.0% | NEW | — |
| 329 | Venture Global, Inc. | $278,250 | 0.0% | -65% | 69.5 | |
| 330 | Vir Biotechnology, Inc. | $273,510 | 0.0% | -4% | 38.2 | |
| 331 | Innoviva, Inc. | $266,774 | 0.0% | -11% | 71.4 | |
| 332 | MANNKIND CORP | $262,714 | 0.0% | +13% | 37.2 | |
| 333 | Fortrea Holdings Inc. | $261,974 | 0.0% | -9% | 45.7 | |
| 334 | CHINA YUCHAI INTERNATIONAL LTD | $260,755 | 0.0% | +0% | — | |
| 335 | ArriVent BioPharma, Inc. | $257,493 | 0.0% | +1% | — | |
| 336 | HARROW, INC. | $251,932 | 0.0% | -10% | 40.5 | |
| 337 | NOVAVAX INC | $246,521 | 0.0% | -9% | 18 | |
| 338 | Xeris Biopharma Holdings, Inc. | $246,122 | 0.0% | -26% | 56.5 | |
| 339 | Karyopharm Therapeutics Inc. | $244,250 | 0.0% | -17% | 15.1 | |
| 340 | CytomX Therapeutics, Inc. | $242,426 | 0.0% | +17% | 8.7 | |
| 341 | Oric Pharmaceuticals, Inc. | $239,917 | 0.0% | +24% | — | |
| 342 | Immunocore Holdings plc | $231,045 | 0.0% | -33% | — | |
| 343 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $226,790 | 0.0% | NEW | 43.8 | |
| 344 | Personalis, Inc. | $223,324 | 0.0% | -10% | 11.3 | |
| 345 | Axogen, Inc. | $221,712 | 0.0% | +92% | 40.8 | |
| 346 | Inhibrx Biosciences, Inc. | $221,241 | 0.0% | -10% | 30 | |
| 347 | Alphatec Holdings, Inc. | $216,250 | 0.0% | +291% | 43.3 | |
| 348 | BrightSpring Health Services, Inc. | $209,220 | 0.0% | NEW | 63.3 | |
| 349 | PALVELLA THERAPEUTICS, INC. | $207,377 | 0.0% | +36% | — | |
| 350 | Entrada Therapeutics, Inc. | $204,446 | 0.0% | +309% | 7.3 | |
| 351 | Brookdale Senior Living Inc. | $201,125 | 0.0% | +400% | 44.1 | |
| 352 | Savara Inc | $200,902 | 0.0% | -10% | — | |
| 353 | ARDELYX, INC. | $200,507 | 0.0% | -10% | 41.9 | |
| 354 | MeiraGTx Holdings plc | $199,124 | 0.0% | +3% | — | |
| 355 | RESMED INC | $194,880 | 0.0% | +0% | 74.3 | |
| 356 | iRhythm Holdings, Inc. | $190,320 | 0.0% | +0% | 54.8 | |
| 357 | Xencor Inc | $189,980 | 0.0% | -9% | 11.6 | |
| 358 | Tectonic Therapeutic, Inc. | $189,166 | 0.0% | -13% | — | |
| 359 | COLLEGIUM PHARMACEUTICAL, INC | $186,864 | 0.0% | -8% | 62.7 | |
| 360 | Contineum Therapeutics, Inc. | $183,699 | 0.0% | -17% | — | |
| 361 | Alvotech | $183,256 | 0.0% | -15% | — | |
| 362 | Cullinan Therapeutics, Inc. | $178,112 | 0.0% | -7% | — | |
| 363 | Wave Life Sciences, Inc. | $177,908 | 0.0% | -8% | 7.5 | |
| 364 | WeRide Inc. | $174,600 | 0.0% | -40% | — | |
| 365 | Aura Biosciences, Inc. | $174,333 | 0.0% | +118% | — | |
| 366 | Olema Pharmaceuticals, Inc. | $173,902 | 0.0% | -2% | — | |
| 367 | BioAge Labs, Inc. | $173,408 | 0.0% | -8% | 26.8 | |
| 368 | Forte Biosciences, Inc. | $170,000 | 0.0% | NEW | — | |
| 369 | Pacira BioSciences, Inc. | $158,867 | 0.0% | -13% | 51.5 | |
| 370 | Vor Biopharma Inc. | $158,768 | 0.0% | +17% | — | |
| 371 | GLOBUS MEDICAL INC | $158,020 | 0.0% | +25% | 79.5 | |
| 372 | Eton Pharmaceuticals, Inc. | $157,832 | 0.0% | -8% | 67.5 | |
| 373 | Solid Biosciences Inc. | $156,523 | 0.0% | +13% | — | |
| 374 | Satellos Bioscience Inc. | $155,500 | 0.0% | +213% | — | |
| 375 | Kura Oncology, Inc. | $154,984 | 0.0% | -9% | 27.6 | |
| 376 | Sana Biotechnology, Inc. | $154,572 | 0.0% | -6% | — | |
| 377 | DIAGEO PLC | $151,436 | 0.0% | +0% | — | |
| 378 | Arbutus Biopharma Corp | $150,902 | 0.0% | -8% | 7.3 | |
| 379 | Janux Therapeutics, Inc. | $149,084 | 0.0% | -10% | 30.1 | |
| 380 | Biohaven Ltd. | $148,800 | 0.0% | -7% | — | |
| 381 | MARAVAI LIFESCIENCES HOLDINGS, INC. | $146,490 | 0.0% | -10% | 24.4 | |
| 382 | Replimune Group, Inc. | $145,471 | 0.0% | -10% | — | |
| 383 | Editas Medicine, Inc. | $143,934 | 0.0% | +156% | 33.4 | |
| 384 | OMEROS CORP | $143,782 | 0.0% | -20% | — | |
| 385 | PALISADE BIO, INC. | $141,890 | 0.0% | NEW | — | |
| 386 | Amphastar Pharmaceuticals, Inc. | $141,603 | 0.0% | -13% | 50.5 | |
| 387 | Theravance Biopharma, Inc. | $139,485 | 0.0% | -9% | 69.2 | |
| 388 | Phathom Pharmaceuticals, Inc. | $137,719 | 0.0% | -9% | 40.9 | |
| 389 | Grifols SA | $137,458 | 0.0% | -10% | — | |
| 390 | ZEVRA THERAPEUTICS, INC. | $134,911 | 0.0% | -6% | 72.8 | |
| 391 | Hemab Therapeutics Holdings, Inc. | $132,228 | 0.0% | NEW | — | |
| 392 | DBV Technologies S.A. | $131,200 | 0.0% | +60% | — | |
| 393 | GERON CORP | $130,685 | 0.0% | -10% | — | |
| 394 | Esperion Therapeutics, Inc. | $129,465 | 0.0% | -3% | 46.3 | |
| 395 | KESTRA MEDICAL TECHNOLOGIES, LTD. | $127,200 | 0.0% | +100% | — | |
| 396 | ARS Pharmaceuticals, Inc. | $126,590 | 0.0% | -10% | 20.3 | |
| 397 | Encompass Health Corp | $126,350 | 0.0% | NEW | 66.9 | |
| 398 | PRECISION BIOSCIENCES INC | $125,760 | 0.0% | NEW | 10.6 | |
| 399 | Candel Therapeutics, Inc. | $120,108 | 0.0% | -10% | — | |
| 400 | Aclaris Therapeutics, Inc. | $117,586 | 0.0% | +4% | 12 | |
| 401 | AMN HEALTHCARE SERVICES INC | $116,532 | 0.0% | +125% | 54.5 | |
| 402 | RIGEL PHARMACEUTICALS INC | $115,208 | 0.0% | -9% | 73.9 | |
| 403 | CASTLE BIOSCIENCES INC | $115,124 | 0.0% | -9% | 40.7 | |
| 404 | Allogene Therapeutics, Inc. | $114,256 | 0.0% | +38% | 33.9 | |
| 405 | PROCEPT BioRobotics Corp | $112,900 | 0.0% | +0% | 33.3 | |
| 406 | MESOBLAST LTD | $112,556 | 0.0% | -10% | 24.9 | |
| 407 | First Tracks Biotherapeutics, Inc. | $111,726 | 0.0% | NEW | — | |
| 408 | NEKTAR THERAPEUTICS | $111,696 | 0.0% | -60% | 9.7 | |
| 409 | 4D Molecular Therapeutics, Inc. | $110,656 | 0.0% | -8% | 34.5 | |
| 410 | IRONWOOD PHARMACEUTICALS INC | $110,294 | 0.0% | -9% | 60.8 | |
| 411 | Prime Medicine, Inc. | $106,069 | 0.0% | -10% | 30.7 | |
| 412 | PHIBRO ANIMAL HEALTH CORP | $105,284 | 0.0% | -8% | 64.8 | |
| 413 | Shattuck Labs, Inc. | $101,609 | 0.0% | NEW | — | |
| 414 | SHOULDER INNOVATIONS, INC. | $101,400 | 0.0% | +39% | 29.5 | |
| 415 | Zai Lab Ltd | $99,560 | 0.0% | -14% | — | |
| 416 | REGENXBIO Inc. | $98,571 | 0.0% | -8% | 26.4 | |
| 417 | IMMUNIC, INC. | $98,368 | 0.0% | NEW | — | |
| 418 | CorMedix Inc. | $98,015 | 0.0% | -11% | 78.6 | |
| 419 | — | SS SPDR S&P BIOTECH ETF - ETP | $96,216 | 0.0% | +0% | — |
| 420 | Surrozen, Inc./DE | $94,718 | 0.0% | +46% | — | |
| 421 | Zura Bio Ltd | $94,400 | 0.0% | -26% | — | |
| 422 | vTv Therapeutics Inc. | $94,125 | 0.0% | NEW | — | |
| 423 | Altimmune, Inc. | $94,091 | 0.0% | +39% | 8 | |
| 424 | — | FAETH THERAPEUTICS INC - Common Stock | $90,000 | 0.0% | NEW | — |
| 425 | Kyverna Therapeutics, Inc. | $86,213 | 0.0% | -5% | — | |
| 426 | ARVINAS, INC. | $85,335 | 0.0% | -31% | 36.6 | |
| 427 | Aquestive Therapeutics, Inc. | $83,054 | 0.0% | -8% | 14.5 | |
| 428 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $83,046 | 0.0% | -8% | 17.1 | |
| 429 | EUPRAXIA PHARMACEUTICALS INC. | $82,625 | 0.0% | +25% | — | |
| 430 | C4 Therapeutics, Inc. | $82,178 | 0.0% | +2% | 18.2 | |
| 431 | Silence Therapeutics plc | $82,076 | 0.0% | -10% | — | |
| 432 | Inventiva S.A. | $81,648 | 0.0% | +35% | — | |
| 433 | — | PROTHENA CORP PLC - Common Stock | $81,570 | 0.0% | -13% | — |
| 434 | Cabaletta Bio, Inc. | $80,705 | 0.0% | +52% | — | |
| 435 | Equillium, Inc. | $80,000 | 0.0% | NEW | 11.7 | |
| 436 | Neurogene Inc. | $79,097 | 0.0% | -9% | 27.4 | |
| 437 | Option Care Health, Inc. | $75,492 | 0.0% | +125% | 56 | |
| 438 | Sagimet Biosciences Inc. | $75,275 | 0.0% | +77% | — | |
| 439 | Evolus, Inc. | $72,738 | 0.0% | -9% | 39 | |
| 440 | — | LAKEFRONT BIOTHERAPEUTIC-ADR - ADR | $71,742 | 0.0% | -9% | — |
| 441 | ESTABLISHMENT LABS HOLDINGS INC. | $68,648 | 0.0% | NEW | 33.9 | |
| 442 | DENTSPLY SIRONA Inc. | $67,904 | 0.0% | +78% | 39.8 | |
| 443 | ENANTA PHARMACEUTICALS INC | $67,476 | 0.0% | -10% | 17.8 | |
| 444 | KAMADA LTD | $67,389 | 0.0% | -10% | — | |
| 445 | PUMA BIOTECHNOLOGY, INC. | $65,699 | 0.0% | -10% | 53.8 | |
| 446 | Immuneering Corp | $63,857 | 0.0% | +12% | — | |
| 447 | Invivyd, Inc. | $63,238 | 0.0% | +5% | 29.7 | |
| 448 | Eledon Pharmaceuticals, Inc. | $63,040 | 0.0% | NEW | — | |
| 449 | Pelthos Therapeutics Inc. | $61,042 | 0.0% | NEW | 17.5 | |
| 450 | Upstream Bio, Inc. | $59,934 | 0.0% | -10% | 19.7 | |
| 451 | ROCKET PHARMACEUTICALS, INC. | $59,433 | 0.0% | -10% | — | |
| 452 | Atea Pharmaceuticals, Inc. | $59,222 | 0.0% | -8% | — | |
| 453 | Vanda Pharmaceuticals Inc. | $58,575 | 0.0% | -9% | 25.6 | |
| 454 | Lexeo Therapeutics, Inc. | $58,174 | 0.0% | -4% | — | |
| 455 | OmniAb, Inc. | $56,757 | 0.0% | -10% | 33 | |
| 456 | Uxin Ltd | $54,250 | 0.0% | +0% | — | |
| 457 | TENAX THERAPEUTICS, INC. | $52,380 | 0.0% | NEW | — | |
| 458 | Lyell Immunopharma, Inc. | $52,182 | 0.0% | -1% | 9.3 | |
| 459 | AVITA Medical, Inc. | $51,625 | 0.0% | +25% | 22.8 | |
| 460 | Autolus Therapeutics plc | $51,080 | 0.0% | -10% | — | |
| 461 | Larimar Therapeutics, Inc. | $50,426 | 0.0% | -14% | — | |
| 462 | Neumora Therapeutics, Inc. | $50,130 | 0.0% | -1% | — | |
| 463 | Alpha Teknova, Inc. | $48,467 | 0.0% | -10% | 26.6 | |
| 464 | Foghorn Therapeutics Inc. | $45,599 | 0.0% | -10% | 16.1 | |
| 465 | Parabilis Medicines, Inc. | $43,792 | 0.0% | NEW | — | |
| 466 | Boundless Bio, Inc. | $42,250 | 0.0% | NEW | — | |
| 467 | BRIGHT MINDS BIOSCIENCES INC. | $42,120 | 0.0% | +20% | — | |
| 468 | SIGA TECHNOLOGIES INC | $41,551 | 0.0% | -10% | 14.9 | |
| 469 | Orchestra BioMed Holdings, Inc. | $41,122 | 0.0% | -5% | 32 | |
| 470 | ROYAL CARIBBEAN CRUISES LTD | $40,009 | 0.0% | NEW | — | |
| 471 | CYBIN INC. | $39,660 | 0.0% | -6% | — | |
| 472 | Fulcrum Therapeutics, Inc. | $38,814 | 0.0% | -10% | 32.9 | |
| 473 | AC Immune SA | $38,549 | 0.0% | -9% | — | |
| 474 | CAPRICOR THERAPEUTICS, INC. | $38,528 | 0.0% | NEW | 13.6 | |
| 475 | ANAVEX LIFE SCIENCES CORP. | $38,200 | 0.0% | -10% | 24.6 | |
| 476 | InflaRx N.V. | $35,840 | 0.0% | NEW | — | |
| 477 | NovaBridge Biosciences | $34,835 | 0.0% | -10% | — | |
| 478 | Coherus Oncology, Inc. | $34,369 | 0.0% | -7% | 5 | |
| 479 | Keros Therapeutics, Inc. | $33,705 | 0.0% | -42% | 27.3 | |
| 480 | Voyager Therapeutics, Inc. | $33,656 | 0.0% | -8% | 8.1 | |
| 481 | CODEXIS, INC. | $32,693 | 0.0% | -10% | 28.9 | |
| 482 | BICYCLE THERAPEUTICS PLC | $31,461 | 0.0% | -10% | — | |
| 483 | LIFECORE BIOMEDICAL, INC. DE | $31,343 | 0.0% | -10% | 29.7 | |
| 484 | Arcturus Therapeutics Holdings Inc. | $30,401 | 0.0% | -10% | 7.5 | |
| 485 | Pyxis Oncology, Inc. | $30,350 | 0.0% | -9% | 16 | |
| 486 | LENZ Therapeutics, Inc. | $28,343 | 0.0% | -10% | 12.8 | |
| 487 | Quantum-Si Inc | $27,863 | 0.0% | -9% | 13.2 | |
| 488 | Caribou Biosciences, Inc. | $27,782 | 0.0% | -5% | 11.7 | |
| 489 | Humacyte, Inc. | $27,575 | 0.0% | +3% | 9.1 | |
| 490 | ALX ONCOLOGY HOLDINGS INC | $25,875 | 0.0% | NEW | — | |
| 491 | Tenaya Therapeutics, Inc. | $25,525 | 0.0% | -10% | — | |
| 492 | Jyong Biotech Ltd. | $25,047 | 0.0% | -8% | — | |
| 493 | ProQR Therapeutics N.V. | $23,250 | 0.0% | -38% | — | |
| 494 | Tiziana Life Sciences Ltd | $23,040 | 0.0% | NEW | — | |
| 495 | ADIAL PHARMACEUTICALS, INC. | $20,480 | 0.0% | NEW | — | |
| 496 | Aardvark Therapeutics, Inc. | $19,999 | 0.0% | -10% | — | |
| 497 | PepGen Inc. | $19,814 | 0.0% | -10% | — | |
| 498 | DiaMedica Therapeutics Inc. | $17,600 | 0.0% | -50% | — | |
| 499 | Black Diamond Therapeutics, Inc. | $16,872 | 0.0% | -10% | 37.2 | |
| 500 | Artiva Biotherapeutics, Inc. | $15,520 | 0.0% | NEW | 9.7 | |
| 501 | Rani Therapeutics Holdings, Inc. | $13,601 | 0.0% | +3% | — | |
| 502 | Veradermics, Inc | $12,294 | 0.0% | NEW | — | |
| 503 | GSK plc | $9,071 | 0.0% | -100% | — | |
| 504 | Inspire Medical Systems, Inc. | $8,922 | 0.0% | NEW | 63.7 | |
| 505 | TANDEM DIABETES CARE INC | $7,545 | 0.0% | -90% | 42.8 | |
| 506 | Alector, Inc. | $7,236 | 0.0% | NEW | 10.9 | |
| 507 | TransMedics Group, Inc. | $6,642 | 0.0% | -90% | 67.2 | |
| 508 | Gossamer Bio, Inc. | $6,148 | 0.0% | -9% | 8.2 | |
| 509 | Tencent Music Entertainment Group | $4,175 | 0.0% | +0% | — | |
| 510 | Camp4 Therapeutics Corp | $3,496 | 0.0% | -95% | 25.3 | |
| 511 | PETROBRAS - PETROLEO BRASILEIRO SA | $2,434 | 0.0% | -100% | 54.3 | |
| 512 | CHIPOTLE MEXICAN GRILL INC | $2,074 | 0.0% | +0% | 65.1 | |
| 513 | HERSHEY CO | $1,755 | 0.0% | +0% | 65.7 |
New Positions (45)
Exited Positions (34)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for China Universal Asset Management Co., Ltd. including:
Track China Universal Asset Management Co., Ltd.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for China Universal Asset Management Co., Ltd. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: China Universal Asset Management Co., Ltd.
13F Pro is an AI hedge fund tracker and stock research platform. For China Universal Asset Management Co., Ltd. (SEC CIK: 1906594), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in China Universal Asset Management Co., Ltd.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.